The 22 references in paper V. Lesnyak N., L. Anan'eva P., O. Koneva A., D. Goryachev V., E. Zvezdkina A., M. Kochanova N., O. Desinova V., O. Ovsyannikova B., M. Starovoytova N., В. Лесняк Н., Л. Ананьева П., О. Конева А., Д. Горячев В., Е. Звездкина А., М. Кочанова Н., О. Десинова В., О. Овсянникова Б., М. Старовойтова Н. (2017) “Полуколичественные визуальные методы оценки выраженности интерстициальных поражений легких по данным компьютерной томографии при системной склеродермии // Semi-quantification image methods for assessing severity of scleroderma-associated interstitial lung disease according to computed tomography data” / spz:neicon:pulmonology:y:2017:i:1:p:41-50

1
American Thoracic Society / European Resperatory Society International Multidisciplinary Consensus Classification of the Idiopatic Interstitial Pneumanias. Am. J. Respir. Crit. Care Med.2002; 165 (2): 277–304. DOI: 10.1164/ajrccm. 165.2.ats01.
(check this in PDF content)
2
Гусева Н.Г. Системная склеродермия и псевдосклеродермические синдромы. М.: Медицина. 1993; 75–82.
(check this in PDF content)
3
Goldin J.G., Lynch D.A., Strollo D.C. et al. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest. 2008; 134 (2): 358–367. DOI: 10.1378/chest.07-2444.
(check this in PDF content)
4
Afeltra A., Zennaro D., Garzia P. et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scan. J. Rheumatol. 2006; 35 (5): 388–394. DOI: 10.1080/03009740600844381.
(check this in PDF content)
5
Теплова Л.В., Ананьева Л.П., Лесняк В.Н. и др. Системная склеродермия с интерстициальным поражением легких: сравнительная клиническая характеристика с больными без поражения легких. Научно(практичес( кая ревматология. 2010; 3: 41–47.
(check this in PDF content)
6
Steen V.D., Medsger T.A. Changes in causes of death in systemic sclerosis, 1972–2002. Ann. Rheum. Dis.2007; 66 (7): 940–944. DOI: 10.1136/ard.2006.066068.
(check this in PDF content)
7
Bouros D., Wells A.U., Nicholson A.G. et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med. 2002; 165 (12): 1581–1586. DOI: 10.1164/rccm.2106012.
(check this in PDF content)
8
Goldin J.G., Lynch D.A., Strollo D.C. et al. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest. 2008; 134 (2): 358–367. DOI: 10.1378/chest.07-2444.
(check this in PDF content)
9
Launay D., Remy-Jardin M., Michon-Pasturel U. et al. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J. Rheumatol.2006; 33: 1789–1801.
(check this in PDF content)
10
Goh N.S., Desai S.R., Veeraraghavan S. et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am. J. Respir. Crit. Care Med. 2008; 177 (11): 1248–1254. DOI: 10.1164/rccm.200706-877OC.
(check this in PDF content)
11
Goldin J., Elashoff R., Kim H.J. et al. Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study. Chest. 2009; 136 (5):1333–1340. DOI: 10.1378/chest.09-0108.
(check this in PDF content)
12
Tochimoto A., Kawazuchi Y., Hara M. et al. Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral ptednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up. Mod. Rheumatol. 2011; 21 (3): 296–301. DOI: 10.1007/s10165-010-0403-6.
(check this in PDF content)
13
Moore O.A., Goh N., Corte T. et al. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology(Oxford). 2013; 52 (1): 155–160. DOI: 10.1093/rheumatology/kes289.
(check this in PDF content)
14
Warrick J.H., Bhalla M., Schabel S.I., Silver R.M. High resolution computed tomography in early scleroderma lung disease.J. Rheum. 1991; 18 (10): 1520–1528.
(check this in PDF content)
15
Wells A.U., Hansell D.M., Rubens M.B. et al. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography. Arthritis Rheum. 1997; 40 (7): 1229–1236.
(check this in PDF content)
16
Kazerooni E.A., Martinez F.J., Flint A. et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring.Am. J. Roentgenol.1997; 169 (4): 977–983. DOI: 10.2214/ajr.169.4.9308447.
(check this in PDF content)
17
Hoogen F., Khanna D., Fransen J. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology / European League against Rheumatism collaborative initiative. Arthritis Rheum.2013; 65 (11): 2737–2747. DOI: 10.1002/art.38098.
(check this in PDF content)
18
Smidt N., Rutjes A., van der Windt D.et al. Reproducibility of the STRAD checklist: an instrument to assess the quality of reporting of diagnostic accuracy studies.BMC Med. Res. Methodol. 2006; 6: 12. DOI:10.1186/1471-2288-6-12.
(check this in PDF content)
19
Wells A.U., Hansell D.M., Corrin B. et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax. 1992; 47: 738–742.
(check this in PDF content)
20
Desai S.R., Veeraraghavan S., Hansell D.M. at al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004; 232 (2): 560–567. DOI: 10.1148/radiol.2322031223.
(check this in PDF content)
21
Camiciotolli G., Orlandi I., Bartolucci M. et al. Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest. 2007; 131 (3): 672–681. DOI: 10.1378/chest.06-1401.
(check this in PDF content)
22
Assayag D., Kaduri S., Hudson M. et al. High resolution computed tomography scoring systems for evaluating interstitial lung disease in systemic sclerosis patients. Rheuma( tology. 2012; S1: 003. DOI: 10.4172/2161-1149.S1-003. Поступила 09.02.16
(check this in PDF content)